Диссертация (1174363), страница 30
Текст из файла (страница 30)
Halloran, N.R. Howes, M. G.Raraty, P. Ghaneh, M. Johnstone, S. Sarkar, H.L. Smart, J.C. Evans, G.P. Aithal, R. Sutton, J.P.Neoptolemos, MG. Lombard// Pancreas. - 2015. – V 44(2). – P. 260-5.212.Nicolaides, A.M. Prevention of venous thromboembolism. International consensus statement/A.M. Nicolaides, D.Bergqvist, R.
Hull// International Angiology. – 1997. – N 16. - P. 3-38.213.Nicolás-Pérez, D. Prevention of post-endoscopic retrograde cholangiopancreatographypancreatitis: acost-effectivenessanalysis/D.Nicolás-Pérez,I.Castilla-Rodríguez,A.Z.Gimeno-García, R. Romero-García, V. Núñez-Díaz, E. Quintero// Pancreas. – 2015. - V 44(2). – P.204-10.214.Ohuchida, J. Randomized controlled trial for efficacy of nafamostat mesilate in preventingpost-endoscopic retrograde cholangiopancreatography pancreatitis/ J.
Ohuchida, K. Chijiiwa, N.Imamura, M. Nagano, M. Hiyoshi// Pancreas. - 2015. – V 44(3). – P. 415-21.215.Olsson, G. The impact of prophylactic pancreatic stenting on post-ERCP pancreatitis: Anationwide, register-based study/ G. Olsson, J. Lübbe, U. Arnelo, E.
Jonas, B. Törnqvist, L. Lundell,L. Enochsson// United European Gastroenterol J. – 2017. - V 5(1). – P.111-118.216.Pancreas/Ed. by H.G. Beger et al.// Blackwell Science Ltd., 1998. – V 1.217.Pande,H.Pharmacologicalpreventionofpost-endoscopicretrogradecholangiopancreatography pancreatitis/ H. Pande, P. Thuluvath// Drugs.
- 2003. – N 63. – P. 17991812.131218.Parekh, P. J. The “Scope” of Post-ERCP Pancreatitis/P. J. Parekh, R. Majithia, S K. Sikka, T.H.Baron// Mayo Clin. Proc. - 2017. – V 92(3). – P. 434-448219.Parekh, D.Laparoscopic-assistedpancreaticnecrosectomy:A new surgicaltion for treatment of severe necrotizing pancreatitis/ D.
Parekh// Arch. Surg. – 2006. – N 141. – P.895-903.220.Park, K.T.1. Is high-dose nafamostat mesilate effective for the prevention of post-ERCPpancreatitis, especially in high-risk patients? / K.T.1. Park, D.H. Kang, C.W. Choi, M. Cho, S.B.Park, H.W. Kim, D.U. Kim, C.W. Chung, K.T.
Yoon// Pancreas. – 2011. - V 40(8). – P. 1215-9221.Patai, A. Effect of Rectal Indomethacin for Preventing Post-ERCP Pancreatitis Depends onDifficulties of Cannulation: Results from a Randomized Study With Sequential Biliary Intubation/A. Patai, N. Solymosi, A.V. Patai// J. Clin. Gastroenterol. – 2015. – V 49(5). – P. 429-437.222.Patai,A. Indomethacin and diclofenac in the prevention of post-ERCP pancreatitis: asystematic review and meta-analysis of prospective controlled trials/ A. Patai, N.
Solymosi, L.Mohacsi, AV. Patai// Gastrointest. Endosc. - 2017. – V 85(6). – P. 1144-1156.223.Prat, F. Nifedipine for prevention of post-ERCP pancreatitis: a prospective, double-blindrandomized study/ F. Prat, J. Amaris, B. Ducot, M. Bocquentin, J. Fritsch, A.D. Choury, G. Pelletier,C. Buffet// Gastrointest Endosc. - 2002. – N 56. – P. 202-208.224.stents/Price, L.H. Good stents gone bad: endoscopic treatment of proximally migrated pancreatic ductL.H.Price, J.J.Brandabur, R.A.Kozarek,M.Gluck,W.L.Traverso,S.Irani//Gastrointest.
Endosc. – 2009. – N 70. – P. 174-9.225.Putignano, A. Identification and Validation of an Individual Risk Score for Acute Post-ERCPPancreatitis/ A. Putignano, A. Mariani, F. Perri, M. Di Leo, A. Giussani, P.A. Testoni// JOP. JPancreas. – 2010. - N 11(5 Suppl.). - P. 516-517.226.Rabenstein, T. 25 years of endoscopic sphincterotomy in Erlangen: assessment of theexperience in 3498 patients/ T. Rabenstein, H.T. Schneider, G.I.
Hahn, C. Ell// Endoscopy. - 1998. – V30(9) (Suppl 2). – P. A 194-201.227.Ranson, J.H. Prognostic signs and the role of operative management in acute pancreatitis/ J.H.Ranson, K.M. Rifkind, D.F. Roses, S.D. Fink, K. Eng, F.C. Spencer// Surg. Gynecol. Obstet. - 1974. V 139(1). – P. 69-81.228.Rashdan, A.
Improved stent characteristics for prophylaxis of post-ERCP pancreatitis/ A.Rashdan,E.L.Fogel,L.McHenry,S.Clin. Gastroenterol. Hepatol. – 2004. – N 2. – P. 322-329.Sherman, M.Temkit,G.A. Lehman//132229.Rectal administration of NSAIDs in the prevention of post-ERCP pancreatitis: acomplementary meta-analysis/ M.H. Zheng, H.H. Xia, Y.P. Chen// Gut.
– 2008. – N 57. – P. 1632–1633.230.Riemann, J.F. Ten years of endoscopic papillotomy/ J.F. Riemann, L. Demling// Endoscopy. -1983. - V 15(4). – P. 191-195.231.Robinson, P.S.A. Pancreatitis computed tomography and maghetic resonance imeging II/P.S.A. Robinson, M.B. Sheridon// European Radiology. – 2000. - V 10(3).
- P. 401-403.232.Rоcha, F.G. Impact of radiologic intervention on mortality in necrotizing pancreatitis: the roleof organ failure/F.G. Rocha,E.Benoit, M.J.Zinner, E.E.Whang, P.A.Banks, S.W.ley, K.J. Mortele// Arch. Surg. – 2009. – N 144. – P. 261-265.233.Romagnuolo, J. Magnetic resonance cholangiopancreatography: a meta-analysis of testperformance in suspected biliary disease/ J. Romagnuolo, M. Bardou, E. Rahme, L. Joseph, C.Reinhold, A.N.
Barkun// Ann. Intern. Med. – 2003. – N 139. - P. 547-57.234.Rudin, D. Somatostatin and gabexate for post-endoscopic retrograde cholangiopancreatographypancreatitis prevention: meta-analysis of randomized placebo-controlled trials/ D. Rudin, A. Kiss, R.V.Wetz, V. M. Sottile// J. Gastroenterol. Hepatol. - 2007. – V 22 (7). – P. 977-83.235.Rudin, D.
Somatostatin bolus injection for post-ERCP pancreatitis prevention: a need forfurther study/ D. Rudin// Gastrointest. Endosc. – 2008. - V 67(1). – P. 190.236.Rustagi, T. Endoscopic retrograde cholangiopancreatography (ERCP)-related adverse events:post-ERCP pancreatitis/ T. Rustagi, PA. Jamidar//Gastrointest. Endosc. Clin. N.
Am. - 2015. - V25(1). – P. 107-21.237.Sahakian, A.B. Prevention and management of post-ERCP pancreatitis/ A.B. Sahakian, J.L.Buxbaum, J. Van Dam// JOP. – 2014. - V 15(6). – P. 544-51.238.Sand, J. Prospective randomized trial of the effect of nifedipine on pancreatic irritation after endoscopic retrograde cholangiopancreatography/ J.
Sand, I. Nordback// Digestion. – 1993. – N 54. – P.105-111.239.Seifert, H. Retroperitoneal endoscopic debridement for infected peripancreatic necrosis/ H.Seifert, T. Wehrmann, T. Schmitt, S. Zeuzem// Lancet. – 2000. – N 356. – P. 653–5.240.Seifert, H. Transluminal endoscopic necrosectomy after acute pancreatitis: a multicentre studywith long-term follow- up (the GEPARD Study)/ H. Seifert, M. Biermer, W. Schmitt, C. Jürgensen, U.Will, R. Gerlach, C. Kreitmair, A.
Meining, T. Wehrmann, T. Rösch// Gut. – 2009. – V 58(9). – P.1260-6.133241.Seta, T. Treatment of acute pancreatitis with protease inhibitors: a meta-analysis/ Seta,Y. Noguchi, T. Shimada, S. Shikata, T. Fukui// Eur. J. Gastroenterol. Hepatol. - 2004. - V 16(12). – P.1287-93.242.Shao, L.M.
Nitroglycerin in the prevention of post-ERCP pancreatitis: a meta-analysis/ ShaoL.M., Q.Y. Chen, M.Y. Chen, J.T. Cai// Dig. Dis. Sci. - 2010. – V 55(1). – P. 1-7.243.Sherman, S.Doesleavinga main pancreaticductstentinplacereducethedence of precut biliary sphincterotomy- induced pancreatitis?: randomized prospective study/ S.Sherman, D.
Earle, L. Bucksot, E. Esber, J. Pezzi, K. Gottlieb, G. Lehman// Am. J. Gastroenterol. –1995. – N 90. – P. 1614.244.Shi, Q.Q. Placement of prophylactic pancreatic stents to prevent post-endoscopic retrogradecholangiopancreatography pancreatitis in high-risk patients: a meta-analysis/ Q.Q. Shi, X.Y. Ning,L.L. Zhan, G.D. Tang, X.P. Lv// World J Gastroenterol. – 2014. - V 20(22). - P. 7040-8.245.Singh, P. Does prophylactic pancreatic stent placement reduce the risk of post-ERCP acutepancreatitis? A meta-analysis of controlled trials/ P.
Singh, A. Das, G. Isenberg, R.C. Wong, M.V.Sivak, D. Agrawal, A. Chak// Gastrointest Endosc. – 2004. – N 60 - P. 544–550.246.Smithline, A. Effect of prophylactic main pancreatic duct stenting on the incidenceof biliary endoscopic sphincterotomy- induced pancreatitis in high-risk patients/A.Smithline, W.Silverman, D. Rogers, R. Nisi, M. Wiersema, P. Jamidar, R. Hawes, G. Lehman// Gastrointest.
Endosc. – 1993. – V 39(5). – P. 652-7.247.Soehendra, N.Palliative gallengangdrainage/ N.Soehendra,V.Reynders-Frederix//Dtsch Med Wochenschr. – 1979. - V 104. - P. 206-209.248.Sofuni, A. Endoscopic pancreatic duct stents reduce the incidence of post-endoscopic retro-grade cholangiopancreatography pancreatitis in high-risk patients/ A. Sofuni, H. Maguchi, T. Mukai,H. Kawakami, A.
Irisawa, K. Kubota, S. Okaniwa, M. Kikuyama, H. Kutsumi, K. Hanada//Clin. Gastroenterol. Hepatol. - 2011. – N 9. – P. 851-88.249.Sofuni, A. Prophylaxis of post-endoscopic retrograde cholangiopancreatography pancreatitis byan endoscopic pancreatic spontaneous dislodgement stent/ A.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
